Form C: Filer Information

Filer CIK:

0002023016

Filer CCC:

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE

TEST

Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?

Would you like a Return Copy?

Submission Contact Information

Name:

Phone Number:

Contact E-Mail Address:

Notify via Filing Website only?

Form C: Issuer Information

Issuer Information

Name of Issuer:

Turn Therapeutics Inc.

Legal Status of Issuer:

Form:

Corporation

Jurisdiction of Incorporation/Organization:

DELAWARE

Date of Incorporation/Organization:

01-06-2015

Physical Address of Issuer:

Address 1:

250

Address 2:

N. Westlake Blvd.

City:

WESTLAKE VILLAGE

State/Country:

CALIFORNIA

Mailing Zip/Postal Code:

91362

Website of Issuer:

https://turntherapeutics.com

Is there a Co-issuer?

Yes

Form C: Offering Information

Offering Information

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

Turn Therapeutics Inc.

Signature:

/s/ Bradley Burnam

Title:

Chief Executive Officer and Chairman, Principal Executive Officer

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Bradley Burnam

Title:

Chief Executive Officer and Chairman (Principal Executive Officer)

Date:

05-12-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Zuraiz Chaudhary

Title:

Chief Financial Officer (Principal Financial and Accounting Officer)

Date:

05-12-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Andrew Gengos

Title:

Director

Date:

05-12-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Dr. Neil Ghodadra

Title:

Director

Date:

05-12-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Dr. Kent Kester

Title:

Director

Date:

05-12-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Arthur F. Golden

Title:

Director

Date:

05-12-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Martin Dewhurst

Title:

Director

Date:

05-12-2026